Top Industry Leaders in the Transarterial Chemoembolization Market
Latest Transarterial Chemoembolization Companies Update:
Boston Scientific Received FDA approval for the Embozap Plus Embolization Bead System in November 2023, offering a versatile option for TACE procedures.
Sirtex Medical Limited Released positive data from a clinical trial on their SIR-Spheres Yttrium-90 resin microspheres for HCC treatment, showing improved survival rates.
Baxter International Launched the Embolic Bead Kit with Microspheres in Asia Pacific, providing healthcare professionals with a comprehensive solution for TACE procedures.
Cook Medical Collaborated with Sirtex Medical to develop and distribute a new delivery system for Yttrium-90 radioembolization, aiming to improve procedure efficiency and patient outcomes.
Isofol Medical AB Received CE Mark approval for their Elucis Pro microcatheter platform in Europe, designed for precise microsphere delivery during TACE procedures.
List of Transarterial Chemoembolization Key companies in the market
- Advaxis Inc.
- Baxter
- Bellicum Pharmaceuticals
- Boston Scientific Corporation
- Cook
- Hikma Pharmaceuticals PLC
- Isofol Medical AB
- Nippon Kayaku Co.
- Novartis
- Pfizer
- Sirtex SIR-Spheres Pty Ltd.
- Spectrum Pharmaceuticals